Dabigatran and warfarin: comparative analysis of safety and cost.

被引：0
|
作者：
Vakil, Niyati H. [1 ]
Leber, Molly [1 ]
Bliss, Gina [1 ]
Yazdi, Marina [1 ]
机构：
[1] Yale New Haven Med Ctr, New Haven, CT 06504 USA
来源：
PHARMACOTHERAPY | 2012年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
6E
引用
收藏
页码：E179 / E179
页数：1
相关论文
共 50 条
  • [41] Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Yao, Xiaoxi
    Abraham, Neena S.
    Sangaralingham, Lindsey R.
    Bellolio, M. Fernanda
    McBane, Robert D.
    Shah, Nilay D.
    Noseworthy, Peter A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [42] Monitoring the Safety and Effectiveness of Dabigatran and Warfarin in Routine Care: An Interim Analysis Using US Healthcare Utilization Data
    Seeger, John D.
    Bartels, Dorothee B.
    Huybrechts, Krista
    Bykov, Katsiaryna
    Zint, Kristina
    Schneeweiss, Sebastian
    CIRCULATION, 2013, 128 (22)
  • [43] Low maintenance cost.
    Snyder, MR
    MODERN PLASTICS, 1996, 73 (02): : 78 - +
  • [44] Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
    Schulman, Sam
    Kakkar, Ajay K.
    Goldhaber, Samuel Z.
    Schellong, Sebastian
    Eriksson, Henry
    Mismetti, Patrick
    Christiansen, Anita Vedel
    Friedman, Jeffrey
    Le Maulf, Florence
    Peter, Nuala
    Kearon, Clive
    CIRCULATION, 2014, 129 (07) : 764 - 772
  • [45] Cost of Hospital Admissions in Medicare Patients With Atrial Fibrillation Taking Warfarin, Dabigatran, or Rivaroxaban
    Vaughan, Mary S.
    Jones, Michael
    Mazur, Alexander
    Cram, Peter
    Ayyagari, Padmaja
    Chrischilles, Elizabeth
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (03) : 360 - 362
  • [46] Dabigatran may be a cost-effective alternative to warfarin for stroke prevention in atrial fibrillation
    不详
    FORMULARY, 2011, 46 (02) : 39 - 39
  • [47] Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
    Harrington, Amanda R.
    Armstrong, Edward P.
    Nolan, Paul E., Jr.
    Malone, Daniel C.
    STROKE, 2013, 44 (06) : 1676 - +
  • [48] Comparison of the Effectiveness and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Newly Diagnosed Atrial Fibrillation
    Hernandez, Inmaculada
    Zhang, Yuting
    Saba, Samir
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (10): : 1813 - 1819
  • [49] Comparative Effectiveness and Safety Between Reduced Dose Dabigatran, Reduced Dose Rivaroxaban and Warfarin Among Oldest Old Atrial Fibrillation Patients
    Lai, Chao-Lun
    Chen, Ho-Min
    Liao, Min-Tsun
    Lin, Ting-Tse
    CIRCULATION, 2017, 136
  • [50] Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis
    Shurrab, Mohammed
    Morillo, Carlos A.
    Schulman, Sam
    Kansal, Nitin
    Danon, Asaf
    Newman, David
    Lashevsky, Ilan
    Healey, Jeff S.
    Crystal, Eugene
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : 1203 - 1210
12345